Targeting Lipid Biology and Fatty Acid Metabolism to Restore Vision Loss in Dry AMD: ELOVL2 Gene Therapy for Dry AMD
Time: 4:00 pm
day: Day1
Details:
- Restoring Retinal Homeostasis Through Lipid Biosynthesis: Understanding how the RPE’s role in fatty acid metabolism and waste clearance impacts photoreceptor integrity and survival
- Discussing ELOVL2 Gene Therapy as a Metabolic Rescue Strategy and how restoring fatty acid elongation supports retinal structure and function in aging and disease
- Evaluating ELOVL2 as a Therapeutic Platform: A potential first-in-class approach for modulating age-related metabolic decline in the retina and redefining treatment paradigms in dry AMD
